Fusion Biopsy Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Biopsy Route (Transrectal, Transperineal), By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, Competition, 2020-2030F

November 2025 | 180 pages | ID: F0C795AE1870EN
TechSci Research

Abstracts

The Global Fusion Biopsy Market, valued at USD 618.92 Million in 2024, is projected to experience a CAGR of 8.60% to reach USD 1015.34 Million by 2030. Fusion biopsy is an advanced diagnostic technique that integrates magnetic resonance imaging with real-time ultrasound to precisely target suspicious lesions for tissue sampling, predominantly within the prostate. This method enhances diagnostic accuracy by guiding the biopsy needle to specific abnormal areas, a considerable improvement over traditional random sampling. The market for fusion biopsy is significantly driven by the increasing global prevalence of prostate cancer and continuous advancements in imaging technologies that improve detection and procedural precision.

Key Market Drivers

The increasing global prevalence of prostate cancer is a primary market driver, fueling demand for precise diagnostic tools. With new diagnoses consistently rising, advanced detection methods are critical for improved patient outcomes. According to the International Agency for Research on Cancer's Global Cancer Observatory, in 2022, approximately 1.5 million new cases of prostate cancer were reported globally, underscoring this persistent demand. Simultaneously, continuous advancements in medical imaging technologies significantly impact market expansion. Improvements in MRI and ultrasound systems, with sophisticated software, enhance fusion biopsy precision. These technological evolutions enable more accurate lesion identification.

Key Market Challenges

The elevated cost associated with fusion biopsy systems and procedures, alongside challenges in securing comprehensive reimbursement, significantly impedes market expansion. The high capital investment required for these advanced diagnostic platforms creates a substantial financial burden for healthcare providers. This limitation particularly affects institutions with restricted budgets and healthcare systems in developing economies, curtailing their ability to acquire and implement fusion biopsy technology.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning is a significant trend transforming the global fusion biopsy market by enhancing diagnostic accuracy and procedural efficiency. AI algorithms analyze complex imaging data, such as MRI, to identify suspicious lesions with greater precision, reducing inter-operator variability and potentially lowering healthcare costs. This technological advancement also facilitates more efficient workflows, with AI systems capable of optimizing lesion segmentation and image texture analysis.

Key Market Players

• Eigen Health Ltd
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• MedCom Inc
• Esaoate SpA
• KOELIS SAS
• Focal Healthcare Inc
• UC-Care Medical Systems Ltd.
• GeoScan Medical

Report Scope:

In this report, the Global Fusion Biopsy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Fusion Biopsy Market, By Biopsy Route:
• Transrectal
• Transperineal
• Fusion Biopsy Market, By End-User:
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers
• Fusion Biopsy Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fusion Biopsy Market.

Available Customizations:

Global Fusion Biopsy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL FUSION BIOPSY MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Biopsy Route (Transrectal, Transperineal)
  5.2.2. By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers)
  5.2.3. By Region
  5.2.4. By Company (2024)
5.3. Market Map

6. NORTH AMERICA FUSION BIOPSY MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Biopsy Route
  6.2.2. By End-User
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Fusion Biopsy Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Biopsy Route
      6.3.1.2.2. By End-User
  6.3.2. Canada Fusion Biopsy Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Biopsy Route
      6.3.2.2.2. By End-User
  6.3.3. Mexico Fusion Biopsy Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Biopsy Route
      6.3.3.2.2. By End-User

7. EUROPE FUSION BIOPSY MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Biopsy Route
  7.2.2. By End-User
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Fusion Biopsy Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Biopsy Route
      7.3.1.2.2. By End-User
  7.3.2. France Fusion Biopsy Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Biopsy Route
      7.3.2.2.2. By End-User
  7.3.3. United Kingdom Fusion Biopsy Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Biopsy Route
      7.3.3.2.2. By End-User
  7.3.4. Italy Fusion Biopsy Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Biopsy Route
      7.3.4.2.2. By End-User
  7.3.5. Spain Fusion Biopsy Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Biopsy Route
      7.3.5.2.2. By End-User

8. ASIA PACIFIC FUSION BIOPSY MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Biopsy Route
  8.2.2. By End-User
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Fusion Biopsy Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Biopsy Route
      8.3.1.2.2. By End-User
  8.3.2. India Fusion Biopsy Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Biopsy Route
      8.3.2.2.2. By End-User
  8.3.3. Japan Fusion Biopsy Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Biopsy Route
      8.3.3.2.2. By End-User
  8.3.4. South Korea Fusion Biopsy Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Biopsy Route
      8.3.4.2.2. By End-User
  8.3.5. Australia Fusion Biopsy Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Biopsy Route
      8.3.5.2.2. By End-User

9. MIDDLE EAST & AFRICA FUSION BIOPSY MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Biopsy Route
  9.2.2. By End-User
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Fusion Biopsy Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Biopsy Route
      9.3.1.2.2. By End-User
  9.3.2. UAE Fusion Biopsy Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Biopsy Route
      9.3.2.2.2. By End-User
  9.3.3. South Africa Fusion Biopsy Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Biopsy Route
      9.3.3.2.2. By End-User

10. SOUTH AMERICA FUSION BIOPSY MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Biopsy Route
  10.2.2. By End-User
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Fusion Biopsy Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Biopsy Route
      10.3.1.2.2. By End-User
  10.3.2. Colombia Fusion Biopsy Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Biopsy Route
      10.3.2.2.2. By End-User
  10.3.3. Argentina Fusion Biopsy Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Biopsy Route
      10.3.3.2.2. By End-User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL FUSION BIOPSY MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Eigen Health Ltd
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Koninklijke Philips N.V.
15.3. Hitachi, Ltd.
15.4. MedCom Inc
15.5. Esaoate SpA
15.6. KOELIS SAS
15.7. Focal Healthcare Inc
15.8. UC-Care Medical Systems Ltd.
15.9. GeoScan Medical

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER